Latest News

Spanish Government Approves National Reimbursement of ORKAMBI® (lumacaftor/ivacaftor) and SYMKEVI® (tezacaftor/ivacaftor) in Combination With KALYDECO® (ivacaftor)

LONDON–(BUSINESS WIRE)–Vertex announces that the Spanish government has approved national reimbursement of ORKAMBI and SYMKEVI in combination with KALYDECO.

Source link

Related posts

Mice sleeping fitfully help unravel mystery of insomnia


Kindness matters in the patient experience


FDA draft guidance on bispecific antibodies still has some kinks


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World